If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Aiko Nagayama is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Neoadjuvant Therapy Medicine & Life Sciences
eribulin Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Antineoplastic Combined Chemotherapy Protocols Medicine & Life Sciences
olanzapine Medicine & Life Sciences
ErbB-2 Receptor Medicine & Life Sciences
Safety Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2014 2018

  • 46 Citations
  • 3 h-Index
  • 6 Article
  • 1 Review article

Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis

Yokoe, T., Hayashida, T., Nagayama, A., Nakashoji, A., Maeda, H., Seki, T., Takahashi, M., Takano, T., Abe, T. & Kitagawa, Y., 2018 Jan 1, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

olanzapine
Antiemetics
Nausea
Dexamethasone
Vomiting
1 Citation (Scopus)

Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial

Hayashida, T., Jinno, H., Mori, K., Sato, H., Matsui, A., Sakurai, T., Hattori, H., Takayama, S., Wada, M., Takahashi, M., Seki, H., Seki, T., Nagayama, A., Matsumoto, A. & Kitagawa, Y., 2018 Jun 28, In : BMC Cancer. 18, 1, 701.

Research output: Contribution to journalArticle

eribulin
Breast Neoplasms
Confidence Intervals
Safety
Therapeutics
8 Citations (Scopus)

The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancer

Nakashoji, A., Hayashida, T., Yokoe, T., Maeda, H., Toyota, T., Kikuchi, M., Watanuki, R., Nagayama, A., Seki, T., Takahashi, M., Abe, T. & Kitagawa, Y., 2018 Jan 1, In : Cancer Treatment Reviews. 62, p. 9-17 9 p.

Research output: Contribution to journalReview article

Neoadjuvant Therapy
Breast Neoplasms
Statistical Models
Network Meta-Analysis
human ERBB2 protein
6 Citations (Scopus)

Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple‑negative breast cancer

Nakashoji, A., Matsui, A., Nagayama, A., Iwata, Y., Sasahara, M. & Murata, Y., 2017 Jan 1, In : Oncology Letters. 14, 4, p. 4135-4141 7 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Ductal Carcinoma
Androgen Receptors
Breast Neoplasms
Drug Therapy

Evaluation of efficacy and safety of upfront weekly nanoparticle albumin-bound paclitaxel for HER2-negative breast cancer

Matsui, A., Tatibana, A., Suzuki, N., Hirata, M., Oishi, Y., Hamaguchi, Y., Murata, Y., Nagayama, A., Iwata, Y. & Okamoto, Y., 2017 Nov 1, In : Anticancer research. 37, 11, p. 6481-6488 8 p.

Research output: Contribution to journalArticle

Open Access
Epidermal Growth Factor
Nanoparticles
Breast Neoplasms
Safety
Confidence Intervals